Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Sci Rep. 2020 Apr 28;10(1):7118. doi: 10.1038/s41598-020-64093-2.
Chitinase 3-like 1 (CHI3L1) is known to play a role as prognostic biomarker in the early stages of multiple sclerosis (MS), and patients with high cerebrospinal fluid CHI3L1 levels have an increased risk for the development of neurological disability. Here, we investigated its potential neurotoxic effect by adding recombinant CHI3L1 in vitro to primary cultures of mouse cortical neurons and evaluating both neuronal functionality and survival by immunofluorescence. CHI3L1 induced a significant neurite length retraction after 24 and 48 hours of exposure and significantly reduced neuronal survival at 48 hours. The cytotoxic effect of CHI3L1 was neuron-specific and was not observed in mouse immune or other central nervous system cells. These results point to a selective neurotoxic effect of CHI3L1 in vitro and suggest a potential role of CHI3L1 as therapeutic target in MS patients.
几丁质酶 3 样蛋白 1(CHI3L1)作为多发性硬化症(MS)早期的预后生物标志物而被大家所熟知,且脑脊液中 CHI3L1 水平较高的患者发生神经功能障碍的风险增加。在此,我们通过在体外向原代培养的小鼠皮质神经元中添加重组 CHI3L1,来研究其潜在的神经毒性作用,并通过免疫荧光评估神经元功能和存活情况。暴露于 CHI3L1 24 和 48 小时后,CHI3L1 诱导明显的神经突回缩,并且在 48 小时时显著降低神经元存活。CHI3L1 的细胞毒性作用是神经元特异性的,在小鼠免疫细胞或其他中枢神经系统细胞中未观察到。这些结果表明 CHI3L1 在体外具有选择性的神经毒性作用,并提示 CHI3L1 可能作为 MS 患者的治疗靶点。